Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

Erica J. Brenner, Michael D. Kappelman, Jean‐Frédéric Colombel et al.|Gastroenterology|2020

Cited by 692